Amanote Research
Register
Sign In
The Change in Free-To-Total Prostate-Specific Antigen During Progression to Androgen-Independent State in Prostate Cancer Patients: Utilization for Intermittent Androgen Suppression Therapy
Prostate Cancer and Prostatic Diseases
- United Kingdom
doi 10.1038/sj.pcan.4500328
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Urology
Date
November 1, 1999
Authors
K Akakura
Publisher
Springer Science and Business Media LLC
Related search
Intermittent Androgen Suppression Therapy for Prostate Cancer Patients: An Update
Prostate-Specific Antigen Dynamics Predict Individual Responses to Intermittent Androgen Deprivation
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Intermittent Androgen Suppression Therapy for Prostate Cancer Patients: A Choice for Improved Quality of Life?
Mathematical Modeling of Prostate Cancer Progression in Response to Androgen Ablation Therapy
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Intermittent Androgen Suppression as a Treatment for Prostate Cancer: A Review
Oncologist
Cancer Research
Medicine
Oncology
Hedgehog Signalling in Androgen Independent Prostate Cancer
European Urology
Urology
Androgen Deprivation Therapy for Prostate Cancer
Treatment of Androgen‐Independent Prostate Cancer
Oncologist
Cancer Research
Medicine
Oncology
Adaptive Phenotype Drives Resistance to Androgen Deprivation Therapy in Prostate Cancer
Cell Communication and Signaling
Biochemistry
Cell Biology
Molecular Biology
